Cytokinetics (CYTK) EPS (Basic) (2016 - 2025)
Historic EPS (Basic) for Cytokinetics (CYTK) over the last 16 years, with Q4 2024 value amounting to -$1.26.
- Cytokinetics' EPS (Basic) rose 9990.96% to -$1.26 in Q4 2024 from the same period last year, while for Dec 2024 it was -$5.26, marking a year-over-year increase of 9990.32%. This contributed to the annual value of -$5.26 for FY2024, which is 9990.32% up from last year.
- As of Q4 2024, Cytokinetics' EPS (Basic) stood at -$1.26, which was up 9990.96% from -$1.36 recorded in Q3 2024.
- In the past 5 years, Cytokinetics' EPS (Basic) ranged from a high of -$0.05 in Q3 2020 and a low of -$1394.3 during Q4 2023
- In the last 5 years, Cytokinetics' EPS (Basic) had a median value of -$1.34 in 2024 and averaged -$150.06.
- Per our database at Business Quant, Cytokinetics' EPS (Basic) crashed by 12274530.7% in 2020 and then skyrocketed by 9990.96% in 2024.
- Cytokinetics' EPS (Basic) (Quarter) stood at -$626.51 in 2020, then soared by 46.19% to -$337.15 in 2021, then soared by 99.56% to -$1.48 in 2022, then crashed by 94108.47% to -$1394.3 in 2023, then skyrocketed by 99.91% to -$1.26 in 2024.
- Its last three reported values are -$1.26 in Q4 2024, -$1.36 for Q3 2024, and -$1.31 during Q2 2024.